Acceleration Point

What Acceleration Point does

Acceleration Point is a privately held, Roanoke, Virginia-based company founded in 2010 (per firmographic records) that provides AI-powered technology and consulting services to pharmaceutical and biotech Medical Affairs teams. Its wholly-owned Kwello division operates a proprietary SaaS platform with three integrated modules: Kwello Insights (field interaction insight capture and analysis), Kwello Social (KOL, DOL, and patient advocacy social monitoring across congresses and digital channels), and Kwello Planning (global KOL strategy coordination across Medical, Commercial, and Regulatory functions with built-in compliance and spend tracking). The platform's standout technical component is ElsieAI, a generative AI conversational engine launched in March 2024 that allows medical teams to query internal insights data in plain language with citation transparency, alongside NLP pipelines processing millions of social posts daily and real-time AI-driven compliance flagging for adverse event and promotional risk.

The business model combines an annual, quote-based SaaS subscription to the Kwello platform (priced by organizational size, deployment scope, and modules selected) with expert-led Medical Affairs consulting and team training services covering medical operations, technology implementation, omnichannel strategy, and medical impact. Go-to-market is a direct enterprise field sales motion aimed at Medical Affairs leaders at pharma and biotech companies, supplemented by thought-leadership channels including the OnPoint Podcast, a 143-resource knowledge hub, webinars, and a 5,000+ LinkedIn community. Acceleration Point reports serving 45+ pharma and biotech clients including 12 of the Top 20 Global Pharma Companies (Sanofi, Biogen, Gilead, Pfizer, Novartis, Roche, AstraZeneca, GSK, Amgen, Merck/MSD, Moderna, and others) with stated 90%+ client retention and 95% client satisfaction, supported by offices in Roanoke and London and coverage of 30+ countries.

Name

Acceleration Point

Legal name

Acceleration Point

Website

https://accelerationpoint.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Acceleration Point provides AI-powered Medical Affairs technology and consulting services to pharmaceutical and biotech companies. Its Kwello Platform delivers field insights capture, KOL social monitoring, and global planning used by 12 of the Top 20 global pharma companies.

Ownership category

akta.pro rank

Headquarters

HQ city

Roanoke

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Kwello Platform Subscription: SaaS platform subscription for the Kwello product suite including Insights, Social, and Planning modules. Delivered as enterprise software with pricing based on organizational size and scope of deployment.
2. Medical Affairs Consulting Services: Expert-led strategic consulting services for Medical Affairs teams covering operations, technology, and engagement strategy. Delivered through flexible partnership models including project-based engagements and ongoing advisory relationships.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Acceleration Point develops and sells the Kwello Platform, an AI-powered SaaS suite that helps pharmaceutical and biotech Medical Affairs teams capture field insights, monitor KOL/DOL social conversations, and coordinate global KOL engagement. The company also delivers expert-led Medical Affairs consulting and MSL team training engagements that complement the platform.

Product overview

Acceleration Point offers a unified product portfolio centered on the Kwello Platform, a proprietary AI-powered SaaS solution for Medical Affairs teams. The platform comprises three integrated modules: Kwello Insights (field insight capture and analysis), Kwello Social (social monitoring for KOLs, DOLs, and patient advocacy), and Kwello Planning (global KOL engagement coordination). A key AI capability is ElsieAI, a generative AI conversational interface within Kwello Insights. The company also provides complementary consulting and training services, plus the OnPoint Podcast as an educational resource. The architecture is a platform-plus-modules model where the Kwello platform serves as the core technology, with specialized modules addressing distinct workflow needs.

Differentiator

Problem solved

Functional benefit

Brands

• Kwello: AI-powered platform providing insight solutions for Medical Affairs teams - including Field Insights, Social Monitoring, and Global KOL Planning capabilities.

Products and services

• Kwello Platform Proprietary AI-powered SaaS platform for pharmaceutical and biotech Medical Affairs teams that structures field interactions, monitors KOL/DOL social conversations, and coordinates global KOL engagement plans into actionable intelligence.
• Kwello Insights Field insights module of the Kwello Platform that structures, analyzes, and enables real-time action on insights from medical field interactions, with built-in compliance and AI-powered quality analysis.
• Kwello Social Social intelligence module of the Kwello Platform that monitors and analyzes real-time social insights from KOLs, DOLs, patient advocacy groups, and Medical Congresses using AI-powered analysis.
• Kwello Planning Global KOL planning module of the Kwello Platform that coordinates KOL strategy across Medical, Commercial, and Regulatory teams with centralized profiles, engagement history, cross-functional visibility, and built-in compliance and spend tracking.
• ElsieAI Generative AI-powered conversational data analysis engine within Kwello Insights that allows Medical Affairs users to query internal insights data through plain-language conversation, surface trends, summaries, and recommendations, and drill down through conversational follow-up — without requiring data science expertise.
• Medical Affairs Consulting Expert-led strategic consulting services covering Medical Impact, Omnichannel Strategy, Medical Operations, and Medical Affairs Technology, delivered through flexible project-based or ongoing advisory engagements for pharma and biotech Medical Affairs teams.
• Team Training Workshops and training programs designed to equip MSLs and Medical Affairs teams with the skills needed for high-value HCP engagement.

Quantifiable outcome

• 16% reduction in expedited reviews and 95% stakeholder satisfaction in medical material review optimization
• +2 more outcomes

Named customers42 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Within3: Life sciences insights management platform focused on capturing, analyzing, and acting on Medical Affairs and clinical insights. Closest direct competitor to Acceleration Point's Kwello Insights and Social modules for pharma Medical Affairs teams.
• Monocl: KOL management and global engagement platform for life sciences. Directly comparable to Kwello Planning, with overlap in KOL profiling, cross-functional engagement, and Medical Affairs workflow support.
• Inizio Medical: Medical Affairs agency and technology provider formed from Ashfield and other agencies. Combines consulting services with proprietary technology, mirroring Acceleration Point's hybrid services-plus-platform model.
• Aktana: AI-powered omnichannel engagement platform for pharma commercial and Medical Affairs teams. Direct peer in the AI-driven pharma intelligence category, with overlapping use cases in KOL engagement and field insight activation.
• Real Chemistry: Healthcare marketing, communications, and AI-powered intelligence firm. Overlaps with Acceleration Point on Medical Affairs consulting and proprietary AI tooling for pharma engagement.
• Fishawack Health: Medical communications and consulting group serving pharma Medical Affairs teams. Comparable hybrid services/technology positioning with focus on strategy, medical communications, and engagement support.

Broad incumbents

• Veeva Systems: Dominant pharma CRM and Vault platform with MedComms and Medical Affairs modules. While broader in scope than Acceleration Point, Veeva is the most direct enterprise competitor as pharma IT buyers consolidate Medical Affairs spend onto Vault.
• IQVIA: Global CRO and life sciences technology leader with Medical Affairs solutions layered onto its R&D and commercial platforms. Competes at the enterprise tier where pharma clients increasingly prefer bundled vendor relationships.
• Salesforce Health Cloud: Generic enterprise CRM with pharma and life sciences solutions. Competes indirectly as pharma IT departments extend Salesforce footprints into Medical Affairs workflows rather than deploying specialized platforms like Kwello.

Emerging players

• Anthill Agency: Specialized KOL engagement and Medical Affairs agency with proprietary tooling. Emerging player in the same Medical Affairs workflow niche, focused on KOL mapping and engagement programs for pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@acceleration_point
• Xx.com/accel_point
• Facebookfacebook.com/accelerationpoint
• LinkedInlinkedin.com/company/acceleration-point

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acceleration Point